Company Filing History:
Years Active: 2015-2016
Title: Jurjen Frankena: Innovator in (Thio)morpholine Derivatives
Introduction
Jurjen Frankena is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of (thio)morpholine derivatives. With a total of 2 patents, his work focuses on compounds that have potential therapeutic applications.
Latest Patents
Frankena's latest patents involve (thio)morpholine derivatives that act as S1P modulators. These compounds are characterized by a specific formula and are designed to have affinity to S1P receptors. They may be utilized in the treatment, alleviation, or prevention of diseases and conditions mediated by S1P receptors. The patents emphasize that certain derivatives are excluded from the scope of the invention, ensuring specificity in their application.
Career Highlights
Jurjen Frankena is currently associated with Abbvie Bahamas Limited, where he continues to innovate in the pharmaceutical sector. His work is pivotal in advancing the understanding and treatment of S1P receptor-related conditions.
Collaborations
Frankena collaborates with esteemed colleagues such as Wouter I Iwema Bakker and Hein K A C Coolen. Their combined expertise contributes to the success of their research and development efforts.
Conclusion
Jurjen Frankena's contributions to the field of pharmaceuticals through his innovative patents on (thio)morpholine derivatives highlight his role as a key inventor. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.